FDA drug approval affects health care around the world, but political shortcuts could hurt
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease.
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.